RKLB 8-K — Smart Summary
99% reductionRocket Lab Corporation entered into an Equity Distribution Agreement on March 17, 2026, enabling the at-the-market offering of up to $1,000,000,000 in shares of Common Stock through multiple sales agents and forward purchasers.
Item 8.01 — Other Events
Other
- On March 17, 2026, Rocket Lab Corporation entered into an Equity Distribution Agreement with 11 sales agents including BofA Securities, Inc., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, Deutsche Bank Securities Inc., and others
- The Company may offer and sell shares of Common Stock ($0.0001 par value) with an aggregate offering price of up to $1,000,000,000
- Sales agents will receive a commission not to exceed 2.00% of the sales price per share for shares sold through them as agent
- The agreement includes provisions for Initially-Priced Forward Transactions and Collared Forward Transactions with Forward Purchasers including Bank of America, N.A., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, Deutsche Bank AG London Branch, and others; Forward Sellers receive a commission of up to 2.00% of the volume weighted average of gross sales prices
- Collared Forward Transactions are available only with Goldman Sachs & Co. LLC or Morgan Stanley & Co. LLC as Collared Forward Purchasers
- The offer and sale is made pursuant to a shelf registration statement on Form S-3 filed March 11, 2025 (automatically effective upon filing), as amended by Post-Effective Amendment No. 1 filed May 27, 2025, with a related prospectus supplement filed March 17, 2026
- The Equity Distribution Agreement may be terminated at any time by either the Company or the Sales Agents upon written notice
§ MORE SUMMARIES
More RKLB Smart Summaries
Other filings for Rocket Lab Corp with a Smart Summary.
8-K$RKLBRocket Lab CorpSmart Summary
8-K Filing
Stockholders approve four proposals including director election and subsidiary
8-K$RKLBRocket Lab CorpSmart Summary
8-K Filing
Launches $3B equity offering program with forward sale provisions
8-K$RKLBRocket Lab CorpSmart Summary
8-K Filing
Prospectus filed for resale of 2.3M shares from Mynaric acquisition
8-K$RKLBRocket Lab CorpSmart Summary
8-K Filing
Record Q1 revenue of $200.3M, up 63.5% YoY
8-K$RKLBRocket Lab CorpSmart Summary
8-K Filing
Acquires Mynaric for $155.3 million in stock
8-K$RKLBRocket Lab CorpSmart Summary
8-K Filing
CEO voluntarily cuts salary to $1, forgoes bonus and 392K unvested shares
8-K$RKLBRocket Lab CorpSmart Summary
8-K Filing
Annual meeting scheduled for May 20, 2026; proposal deadline moved to March 22
8-K$RKLBRocket Lab CorpSmart Summary
8-K Filing
Record annual revenue of $602M on 38% growth; backlog jumps 73% to $1.85B
Never miss a RKLB filing
Get real-time email alerts when RKLB files with the SEC.